Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Changing paradigm of cancer therapy: precision medicine by next-generation sequencing

Yuan Xue and William R. Wilcox
Cancer Biology & Medicine March 2016, 13 (1) 12-18; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0003
Yuan Xue
1Fulgent Diagnostics, Temple City, CA 91780, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
William R. Wilcox
2Department of Human Genetics, Emory University, Atlanta, GA 30322, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 13 no. 1 12-18
DOI 
https://doi.org/10.28092/j.issn.2095-3941.2016.0003

Published By 
Cancer Biology & Medicine
History 
  • Received January 6, 2016
  • Accepted February 16, 2016
  • Published online March 1, 2016.

Copyright & Usage 
Copyright: © 2016, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Yuan Xue1⇑ and
  2. William R. Wilcox2
  1. 1Fulgent Diagnostics, Temple City, CA 91780, USA
  2. 2Department of Human Genetics, Emory University, Atlanta, GA 30322, USA
  1. Correspondence to: Yuan Xue, E-mail: yxue618{at}gmail.com
View Full Text
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 13 (1)
Cancer Biology & Medicine
Vol. 13, Issue 1
1 Mar 2016
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
Yuan Xue, William R. Wilcox
Cancer Biology & Medicine Mar 2016, 13 (1) 12-18; DOI: 10.28092/j.issn.2095-3941.2016.0003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
Yuan Xue, William R. Wilcox
Cancer Biology & Medicine Mar 2016, 13 (1) 12-18; DOI: 10.28092/j.issn.2095-3941.2016.0003
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Technical perspectives of NGS in solid tumor tissue
    • The impact of NGS on precision cancer therapy
    • Limitations and concerns of NGS
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
  • Google Scholar

More in this TOC Section

  • The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity
  • Senescent macrophages in cancer: roles in tumor progression and treatment opportunities
  • Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Show more Review

Similar Articles

Keywords

  • precision medicine
  • cancer therapy
  • next-generation sequencing
  • solid tumor

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire